Clinical Trial

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

Study acronym: NAC-AUD
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2023 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-06-02; most recent amendment 2023-03-14.
Status change: Not Yet Recruiting → Recruiting 2023-03-14
Trial Details
NCT Number NCT05408247
Lead Sponsor University of Sydney
Collaborators: Monash University
Conditions Alcohol Use Disorder (AUD)
Enrollment 280 participants
Start Date 2023-02-16
Primary Completion 2025-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2023-03-16